- Home
- INDV vs QLYS Comparison
INDV vs QLYS Comparison
Compare INDV & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | QLYS |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | INDV | QLYS |
|---|---|---|
| Price | $32.54 | $85.13 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $136.00 |
| AVG Volume (30 Days) | ★ 2.2M | 757.2K |
| Earning Date | 06-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | 16.99 |
| EPS | 1.64 | ★ 5.44 |
| Revenue | ★ $1,239,000,000.00 | $321,607,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | $20.09 | ★ $15.30 |
| Revenue Growth | 4.29 | ★ 15.32 |
| 52 Week Low | $8.69 | $74.51 |
| 52 Week High | $38.00 | $155.47 |
Technical Indicators
Market Signals| Indicator | INDV | QLYS |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 43.51 |
| Support Level | $31.70 | $83.60 |
| Resistance Level | $32.42 | $92.02 |
| Average True Range (ATR) | 1.18 | 4.63 |
| MACD | 0.39 | 0.11 |
| Stochastic Oscillator | 73.89 | 61.12 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.